Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackson T Wright

Showing results (151-160 of 189) with videos related to

Pageof 19
Sort By:
The New England Journal of Medicine|August 24, 2017
Cost-Effectiveness of Intensive versus Standard Blood-Pressure ControlAdam P Bress, Brandon K Bellows, Jordan B King, et al.
Hypertension (Dallas, Tex. : 1979)|November 10, 2021
SPRINT Revisited: Updated Results and ImplicationsJackson T Wright, Paul K Whelton, Karen C Johnson, et al.
Annals of Internal Medicine|September 10, 2020
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension : A Systematic Review and Individual Participant-based Meta-analysisStephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, et al.
JAMA|October 17, 2023
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-AnalysisStephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, et al.
BMC Nephrology|February 25, 2021
Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomesSrinivasan Beddhu, Robert E Boucher, Jie Sun, et al.
Archives of Internal Medicine|January 30, 2008
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Jackson T Wright, Sonja Harris-Haywood, Sara Pressel, et al.
Journal of the American Society of Nephrology : JASN|August 13, 2016
BP Control and Long-Term Risk of ESRD and MortalityElaine Ku, Jennifer Gassman, Lawrence J Appel, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2006
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trialFrans H H Leenen, Chuke E Nwachuku, Henry R Black, et al.
JAMA Neurology|March 7, 2022
Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical TrialSudipto Dolui, John A Detre, Sarah A Gaussoin, et al.
Journal of the American Society of Hypertension : JASH|September 17, 2018
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesPaul K Whelton, Robert M Carey, Wilbert S Aronow, et al.
Pageof 19

Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|August 24, 2017
Cost-Effectiveness of Intensive versus Standard Blood-Pressure ControlAdam P Bress, Brandon K Bellows, Jordan B King, et al.
Hypertension (Dallas, Tex. : 1979)|November 10, 2021
SPRINT Revisited: Updated Results and ImplicationsJackson T Wright, Paul K Whelton, Karen C Johnson, et al.
Annals of Internal Medicine|September 10, 2020
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension : A Systematic Review and Individual Participant-based Meta-analysisStephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, et al.
JAMA|October 17, 2023
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-AnalysisStephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, et al.
BMC Nephrology|February 25, 2021
Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomesSrinivasan Beddhu, Robert E Boucher, Jie Sun, et al.
Archives of Internal Medicine|January 30, 2008
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Jackson T Wright, Sonja Harris-Haywood, Sara Pressel, et al.
Journal of the American Society of Nephrology : JASN|August 13, 2016
BP Control and Long-Term Risk of ESRD and MortalityElaine Ku, Jennifer Gassman, Lawrence J Appel, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2006
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trialFrans H H Leenen, Chuke E Nwachuku, Henry R Black, et al.
JAMA Neurology|March 7, 2022
Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical TrialSudipto Dolui, John A Detre, Sarah A Gaussoin, et al.
Journal of the American Society of Hypertension : JASH|September 17, 2018
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesPaul K Whelton, Robert M Carey, Wilbert S Aronow, et al.
Pageof 19